SEC Form 4 
FORM 4	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 	  
OMB APPROVAL
OMB Number:	3235-0287	
Estimated average burden	
hours per response:	0.5	

	
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).			
1. Name and Address of Reporting Person*
COPPOLA ARTHUR M	

(Last)	(First)	(Middle)	
THE MACERICH COMPANY	
401 WILSHIRE BOULEVARD, SUITE 700	

(Street) 
SANTA MONICA	CA	90401	

(City)	(State)	(Zip)	
	2. Issuer Name and Ticker or Trading Symbol 
MACERICH CO [ MAC ] 	5. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
X	Director		10% Owner	
X	Officer (give title below)		Other (specify below)	
Chairman & CEO 	
		
	3. Date of Earliest Transaction (Month/Day/Year)
01/01/2017 		
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) 
X	Form filed by One Reporting Person	
	Form filed by More than One Reporting Person	
	
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1. Title of Security (Instr. 3) 	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8) 	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 	5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 	7. Nature of Indirect Beneficial Ownership (Instr. 4) 	
			Code	V	Amount	(A) or (D)	Price				
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 	
1. Title of Derivative Security (Instr. 3) 	2. Conversion or Exercise Price of Derivative Security 	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8) 	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 	6. Date Exercisable and Expiration Date (Month/Day/Year)	7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 	8. Price of Derivative Security (Instr. 5) 	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 	11. Nature of Indirect Beneficial Ownership (Instr. 4) 	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					
LTIP Units(1) 	(1)	01/01/2017		A		31,761		(1)(2) 	(1) 	Common Stock	31,761	$0 	90,365(3) 	D		
Explanation of Responses:	
1. Represents units of limited partnership interest in The Macerich Partnership, L.P. (the "Partnership"), of which the Issuer is the general partner, issued as compensation pursuant to the Issuer's equity based compensatory programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes and time vesting, each LTIP Unit may be converted into a common unit of limited partnership interest in the Partnership (a "Common Unit"). Each Common Unit acquired upon conversion of a LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common Unit so presented for one share of Common Stock. The rights to convert LTIP Units into Common Units and redeem Common Units do not have expiration dates.	
2. LTIP Units vest one-third on December 29, 2017, one-third on December 31, 2018 and one-third on December 31, 2019.	
3. In addition, the reporting person holds 196,053 shares of common stock and the following limited partnership units in the Partnership, which are generally redeemable upon certain circumstances for an equal number of shares of The Macerich Company's common stock: 706,581 OP Units held directly by the reporting person and 1,764,055 OP Units held through family limited liabilities companies of which the reporting person is the sole manager.	
	Thomas J. Leanse for ARTHUR M. COPPOLA	01/04/2017	
	** Signature of Reporting Person	Date	
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).	
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.	
                               SECTION 16 REPORTS

                              CONFIRMING STATEMENT

         This statement confirms that the undersigned, Arthur M. Coppola, has
authorized and designated THOMAS J. LEANSE and/or LISA PENA (the
"Agents") to execute and file on the undersigned's behalf all Forms 4 and 5
(including any amendments thereto) that the undersigned may be required to file
with the U. S. Securities and Exchange Commission as a result of the
undersigned's ownership of or transactions in securities of THE MACERICH COMPANY
(the "Corporation"). The authority of the Agents under this Statement shall
continue until the undersigned is no longer required to file Forms 4 and 5
with regard to the undersigned's ownership of or transactions in securities of
the Corporation, unless earlier revoked in writing. The undersigned acknowledges
that the Agents are not assuming any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.

Date: April 20, 2016              Signature: /s/ Arthur M. Coppola
                                             ----------------------------
                                             Arthur M. Coppola